PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAE4. A total of 15 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $78,000 | +5.4% | 52,000 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $74,000 | -22.1% | 52,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $95,000 | +18.8% | 52,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $80,000 | 0.0% | 52,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $80,000 | +6.7% | 52,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $75,000 | – | 52,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 25,974,000 | $38,616,000 | 27.00% |
| BASSO CAPITAL MANAGEMENT, L.P. | 20,221,000 | $31,175,000 | 6.19% |
| WHITEBOX ADVISORS LLC | 34,269,000 | $52,646,000 | 2.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 17,710,000 | $27,295,000 | 0.54% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 28,000,000 | $43,015,000 | 0.52% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,500,000 | $3,854,000 | 0.10% |
| Castle Creek Arbitrage, LLC | 1,000,000 | $1,544,000 | 0.07% |
| AQR Capital Management | 7,925,000 | $12,214,000 | 0.04% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 20,550,000 | $31,813,000 | 0.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,224,000 | $26,611,000 | 0.02% |